China Regenerative Medicine International Limited (8158.HK)
Market: HKEX |
Currency: HKD
Address: Miramar Tower
China Regenerative Medicine International Limited, an investment holding company, engages in the provision of healthcare products and services in Hong Kong and the People's Republic of China. It operates through Aesthetic Medical and Beauty Services; and Medical Services segments. The company offers medical beauty products and services; and medical products and services. The company was formerly known as China Bio-Med Regeneration Technology Limited and changed its name to China Regenerative Medicine International Limited in March 2015. China Regenerative Medicine International Limited was founded in 1995 and is headquartered in Tsim Sha Tsui, Hong Kong.
📈 China Regenerative Medicine International Limited Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
-
-
Upside/Downside from Analyst Target:
-
-
Broker Call:
-
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
200-500%
-
Net Income Growth Range (1Y):
200-500%
-
Revenue Growth Range (1Y):
<0%
💰 Dividend History
Year |
Annual Yield (%) |
Total Amount |
Current Yield (%) |
Ex Date |
Pay Date |
Particulars |
2023 |
- |
$0.100000 |
- |
2023-09-06 |
- |
Stock split |
$0.100000 |
- |
2023-08-23 |
- |
Stock split |
Total Amount for 2023: $0.200000 |
2019 |
- |
$0.050000 |
- |
2019-05-16 |
- |
Stock split |
$0.050000 |
- |
2019-04-24 |
- |
Stock split |
Total Amount for 2019: $0.100000 |
📅 Earnings & EPS History for China Regenerative Medicine International Limited
Date | Reported EPS |
---|
2017-12-07 | - |
2017-09-07 | - |
2017-07-16 | - |
2017-03-15 | - |
2016-12-13 | - |
2016-09-08 | - |
📰 Related News & Research
No related articles found for "china regenerative".